The Global Hepatitis B Vaccines Market Size was estimated at USD 1043.99 million in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
Report Overview:
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
This report provides a deep insight into the global Hepatitis B Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis B Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis B Vaccines market in any manner.
Global Hepatitis B Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- GSK
- NCPC
- Merck
- Bio Kangtai
- Dynavax
- Hissen
- KM Biologics
- LG Life Sciences
- Serum Institute
Market Segmentation (by Type)
- Yeast Derived
- CHO Derived
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hepatitis B Vaccines Market
- Overview of the regional outlook of the Hepatitis B Vaccines Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis B Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Vaccines
1.2 Key Market Segments
1.2.1 Hepatitis B Vaccines Segment by Type
1.2.2 Hepatitis B Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hepatitis B Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hepatitis B Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hepatitis B Vaccines Market Competitive Landscape
3.1 Global Hepatitis B Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis B Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hepatitis B Vaccines Sales Sites, Area Served, Product Type
3.6 Hepatitis B Vaccines Market Competitive Situation and Trends
3.6.1 Hepatitis B Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis B Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Vaccines Industry Chain Analysis
4.1 Hepatitis B Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hepatitis B Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Hepatitis B Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Hepatitis B Vaccines Price by Type (2019-2024)
7 Hepatitis B Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Vaccines Market Sales by Application (2019-2024)
7.3 Global Hepatitis B Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Hepatitis B Vaccines Sales Growth Rate by Application (2019-2024)
8 Hepatitis B Vaccines Market Segmentation by Region
8.1 Global Hepatitis B Vaccines Sales by Region
8.1.1 Global Hepatitis B Vaccines Sales by Region
8.1.2 Global Hepatitis B Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis B Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis B Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis B Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis B Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis B Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GSK
9.1.1 GSK Hepatitis B Vaccines Basic Information
9.1.2 GSK Hepatitis B Vaccines Product Overview
9.1.3 GSK Hepatitis B Vaccines Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Hepatitis B Vaccines SWOT Analysis
9.1.6 GSK Recent Developments
9.2 NCPC
9.2.1 NCPC Hepatitis B Vaccines Basic Information
9.2.2 NCPC Hepatitis B Vaccines Product Overview
9.2.3 NCPC Hepatitis B Vaccines Product Market Performance
9.2.4 NCPC Business Overview
9.2.5 NCPC Hepatitis B Vaccines SWOT Analysis
9.2.6 NCPC Recent Developments
9.3 Merck
9.3.1 Merck Hepatitis B Vaccines Basic Information
9.3.2 Merck Hepatitis B Vaccines Product Overview
9.3.3 Merck Hepatitis B Vaccines Product Market Performance
9.3.4 Merck Hepatitis B Vaccines SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Bio Kangtai
9.4.1 Bio Kangtai Hepatitis B Vaccines Basic Information
9.4.2 Bio Kangtai Hepatitis B Vaccines Product Overview
9.4.3 Bio Kangtai Hepatitis B Vaccines Product Market Performance
9.4.4 Bio Kangtai Business Overview
9.4.5 Bio Kangtai Recent Developments
9.5 Dynavax
9.5.1 Dynavax Hepatitis B Vaccines Basic Information
9.5.2 Dynavax Hepatitis B Vaccines Product Overview
9.5.3 Dynavax Hepatitis B Vaccines Product Market Performance
9.5.4 Dynavax Business Overview
9.5.5 Dynavax Recent Developments
9.6 Hissen
9.6.1 Hissen Hepatitis B Vaccines Basic Information
9.6.2 Hissen Hepatitis B Vaccines Product Overview
9.6.3 Hissen Hepatitis B Vaccines Product Market Performance
9.6.4 Hissen Business Overview
9.6.5 Hissen Recent Developments
9.7 KM Biologics
9.7.1 KM Biologics Hepatitis B Vaccines Basic Information
9.7.2 KM Biologics Hepatitis B Vaccines Product Overview
9.7.3 KM Biologics Hepatitis B Vaccines Product Market Performance
9.7.4 KM Biologics Business Overview
9.7.5 KM Biologics Recent Developments
9.8 LG Life Sciences
9.8.1 LG Life Sciences Hepatitis B Vaccines Basic Information
9.8.2 LG Life Sciences Hepatitis B Vaccines Product Overview
9.8.3 LG Life Sciences Hepatitis B Vaccines Product Market Performance
9.8.4 LG Life Sciences Business Overview
9.8.5 LG Life Sciences Recent Developments
9.9 Serum Institute
9.9.1 Serum Institute Hepatitis B Vaccines Basic Information
9.9.2 Serum Institute Hepatitis B Vaccines Product Overview
9.9.3 Serum Institute Hepatitis B Vaccines Product Market Performance
9.9.4 Serum Institute Business Overview
9.9.5 Serum Institute Recent Developments
10 Hepatitis B Vaccines Market Forecast by Region
10.1 Global Hepatitis B Vaccines Market Size Forecast
10.2 Global Hepatitis B Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis B Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis B Vaccines Market Size Forecast by Region
10.2.4 South America Hepatitis B Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis B Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Hepatitis B Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hepatitis B Vaccines by Type (2025-2030)
11.1.2 Global Hepatitis B Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hepatitis B Vaccines by Type (2025-2030)
11.2 Global Hepatitis B Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Hepatitis B Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Hepatitis B Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis B Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis B Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2022)
Table 10. Global Market Hepatitis B Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hepatitis B Vaccines Sales Sites and Area Served
Table 12. Manufacturers Hepatitis B Vaccines Product Type
Table 13. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis B Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Vaccines Market Challenges
Table 22. Global Hepatitis B Vaccines Sales by Type (Kilotons)
Table 23. Global Hepatitis B Vaccines Market Size by Type (M USD)
Table 24. Global Hepatitis B Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Hepatitis B Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Hepatitis B Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Hepatitis B Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hepatitis B Vaccines Sales (Kilotons) by Application
Table 30. Global Hepatitis B Vaccines Market Size by Application
Table 31. Global Hepatitis B Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Hepatitis B Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Hepatitis B Vaccines Market Share by Application (2019-2024)
Table 35. Global Hepatitis B Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hepatitis B Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hepatitis B Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Hepatitis B Vaccines Basic Information
Table 44. GSK Hepatitis B Vaccines Product Overview
Table 45. GSK Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Hepatitis B Vaccines SWOT Analysis
Table 48. GSK Recent Developments
Table 49. NCPC Hepatitis B Vaccines Basic Information
Table 50. NCPC Hepatitis B Vaccines Product Overview
Table 51. NCPC Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. NCPC Business Overview
Table 53. NCPC Hepatitis B Vaccines SWOT Analysis
Table 54. NCPC Recent Developments
Table 55. Merck Hepatitis B Vaccines Basic Information
Table 56. Merck Hepatitis B Vaccines Product Overview
Table 57. Merck Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Hepatitis B Vaccines SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Bio Kangtai Hepatitis B Vaccines Basic Information
Table 62. Bio Kangtai Hepatitis B Vaccines Product Overview
Table 63. Bio Kangtai Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bio Kangtai Business Overview
Table 65. Bio Kangtai Recent Developments
Table 66. Dynavax Hepatitis B Vaccines Basic Information
Table 67. Dynavax Hepatitis B Vaccines Product Overview
Table 68. Dynavax Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Dynavax Business Overview
Table 70. Dynavax Recent Developments
Table 71. Hissen Hepatitis B Vaccines Basic Information
Table 72. Hissen Hepatitis B Vaccines Product Overview
Table 73. Hissen Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hissen Business Overview
Table 75. Hissen Recent Developments
Table 76. KM Biologics Hepatitis B Vaccines Basic Information
Table 77. KM Biologics Hepatitis B Vaccines Product Overview
Table 78. KM Biologics Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. KM Biologics Business Overview
Table 80. KM Biologics Recent Developments
Table 81. LG Life Sciences Hepatitis B Vaccines Basic Information
Table 82. LG Life Sciences Hepatitis B Vaccines Product Overview
Table 83. LG Life Sciences Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. LG Life Sciences Business Overview
Table 85. LG Life Sciences Recent Developments
Table 86. Serum Institute Hepatitis B Vaccines Basic Information
Table 87. Serum Institute Hepatitis B Vaccines Product Overview
Table 88. Serum Institute Hepatitis B Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Serum Institute Business Overview
Table 90. Serum Institute Recent Developments
Table 91. Global Hepatitis B Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Hepatitis B Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Hepatitis B Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Hepatitis B Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Hepatitis B Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Hepatitis B Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Hepatitis B Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Hepatitis B Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Hepatitis B Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Hepatitis B Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Hepatitis B Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Hepatitis B Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Hepatitis B Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Hepatitis B Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Hepatitis B Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Hepatitis B Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Hepatitis B Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Hepatitis B Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Hepatitis B Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Vaccines Market Size by Country (M USD)
Figure 11. Hepatitis B Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis B Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis B Vaccines Market Share by Type
Figure 18. Sales Market Share of Hepatitis B Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Hepatitis B Vaccines by Type in 2023
Figure 20. Market Size Share of Hepatitis B Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Hepatitis B Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis B Vaccines Market Share by Application
Figure 24. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Hepatitis B Vaccines Sales Market Share by Application in 2023
Figure 26. Global Hepatitis B Vaccines Market Share by Application (2019-2024)
Figure 27. Global Hepatitis B Vaccines Market Share by Application in 2023
Figure 28. Global Hepatitis B Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hepatitis B Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hepatitis B Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hepatitis B Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hepatitis B Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hepatitis B Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region in 2023
Figure 44. China Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hepatitis B Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Hepatitis B Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hepatitis B Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hepatitis B Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hepatitis B Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hepatitis B Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hepatitis B Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Hepatitis B Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Hepatitis B Vaccines Market Share Forecast by Application (2025-2030)
